Laser Doping: Bright to the eye, invisible to drug tests

Performance-enhancing Laser Doping: Bright to the eye, invisible to drug tests

Although the concept may sound like science fiction, intravenous (in the vein) lasers are now used clinically to treat a range of ailments, and so far their surprising effects of ‘superhuman’ performance have more than just the Star Trek fans tuning in.

In a recent Italian pilot study conducted by Doctors Francesco Raggi and Giuseppe Vallesi, four male bodybuilders were recruited to investigate the effects caused by concentrated lasers applied to the circulating blood.

The lasers, similar to those now FDA-approved and patented by German Technologist Weber Medical, are far more advanced than a typical laser light one might find at a weekend market. Intravenous (IV) lasers are modern medical devices which are inserted through a standard needle attachment and into a vein in the arm or hand.

As the venous blood rushes over the tip of the needle, concentrated beams of laser at carefully tuned wavelengths drench the blood cells and the fluid plasma in a process called ‘intravenous irradiation’.

For the researchers, the treatments were fast and effective with easily measurable results.

For each of the four patients, the treatments were ever simpler. Just ten short 20 – 30 minute daily visits were required over a ten day period before their strength and endurance was tested each month for the next 6 months. The results that followed were astounding.



After their final laser session, doctors recorded the strength and endurance of each bodybuilder as a starting point. By the first follow-up four weeks later, both the strength tests (bench press and dead lift weight) and endurance test (skipping time) had improved by more than 10% (strength) and 80% (endurance).

What was additionally impressive was how long these results continued. At 2, 3, 4 and even 5 months following the final treatment these results were strikingly similar to the improvements observed after the first follow-up test.

By the 6 month mark, all results had reduced and by all accounts had, for a lack of more succinct term, ‘worn off’. Although this therapeutic window seemed to abruptly close after the 20th week, this timing was closely associated with the average life-span of a red blood cell in circulation (15-17 weeks).

In conclusion, Doctors observed a significant increase in muscular and cardiovascular performance for up to 16 weeks post-treatment. The study concluded ascribing the performance-enhancing effects to a laser-induced change in the red blood cells and potentially other factors within the blood.

This study was distributed in a variety of forms and was translated to both Dutch and English with a few notable errors. Although the study was not peer-reviewed nor what a typical clinical researcher would call conclusive, the study may provide some insight into the potential therapeutic effects achievable with medical laser therapy.



*Please read: Although the information provided on this page may describe a particular patient experience and/or outcome, readers must understand that each patient presents with a unique medical history and may be recommended a different treatment/surgery by their surgeon to that described above. Individual results may vary between surgery centre/hospital, surgeon, surgery type and patient. Although SkyGen agrees to share all updates from patients at their request, SkyGen does not endorse any physical activities attempted by patients following surgery which do not follow the explicit instructions provided by their surgeon. SkyGen encourages all patients to discuss the risks of such activities with medical professionals before attempting these themselves.

Written by SkyGen Public Relations

This content is copyright and property of SkyGen Spinal & Orthopaedic. It was written to educate our patients in making informed decisions regarding their own healthcare. SkyGen is Australia's largest international collaboration between world class regenerative medicine clinics and orthopaedic hospitals.